References for Sex hormones and health

22/11/2017 13:45


  1. Schaffir, J., Worley, B. & Gurr, T. (2016). Combined hormonal contraception and its effects on mood: a critical review. The European Journal of Contraception and Reproductive health Care. 21(5): 347-355.
  2. Skovlund, C. et al. (2016). Association of hormonal contraception with depression. JAMA Psychiatry. 73(11): 1154-1162.
  3. Norman, A. & Henry, H. (2015). Hormones. (3rd ed.). London: Academic Press.
  4. Weinbauer, G. et al. (2010). Physiology of testicular function. In Nieschlag, E et al. (eds.). Andrology. Berlin: Springer-Verlag.
  5. Davis, S. & Worsley, R. (2013). Androgen treatment of post-menopausal women. Journal of Steroid Biochemistry and Molecular Biology. 142: 107-114.
  6. Giatti, S., Melcangi, C. & Pesaresi, M. (2016). The other side of progestins: effects in the brain. Journal of Molecular Endocrinology. 57: R109-R126.
  7. Barrett-Connor, E. et al. (2006). Effects of raloxifene on cardiovascular events and breast cancer in post-menopausal women. New England Journal of Medicine. 355(2): 125-137. 
  8. Tchaikovski, S. & Rosing, J. (2010). Mechanisms of estrogen-induced venous thromboembolism. Thrombosis Research. 126(1): 5-11.
  9. Woods, G. et al. (2016). A review of hormonal contraception and venous thromboembolism in adolescents. Journal of Pediatric and Adolescent Gynecology. 29(5): 402-408.
  10. Eisenberger, A. & Westhoff, C. (2014). Hormone replacement therapy and venous thromboembolism. The Journal of Steroid Biochemistry and Molecular Biology. 142: 76-82.
  11. Mohammed, K. et al. (2015). Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis. The Journal of Clinical Endocrinology and Metabolism. 100: 4012-4020.
  12. Scarab, P-Y., et al. (2016). Letter to the editor: Transdermal vs oral estrogen therapy and venous thromboembolism: Upgrade the level of evidence. The Journal of Clinical Endocrinology and Metabolism. 101(2): L30-L31.
  13. Brinton, R. et al. (2015). Perimenopause as a neurological transition state. Nature Reviews Endocrinology. 11: 393-405.
  14. Soares, C. & Zitek, B. (2008). Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? Journal of Psychiatry and Neuroscience. 33(4): 331-343.
  15. Dubey, N. et al. (2017). The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Molecular Psychiatry. 00:1-13.
  16. Gordon, j. et al. (2015). Ovarian hormone fluctuations, neurosteroids and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. American Journal of Psychiatry. 172(3):227-236.
  17. Gurney, E. et al. (2014). The Women’s Health Initiative trial and related studies: 10 years later: A clinician’s view. The Journal of Steroid Biochemistry and Molecular Biology. 142: 4-11.
  18. Lobo, R. (2014). Forward. The Journal of Steroid Biochemistry and Molecular Biology. 142: 3.
  19. NICE: National Institute for Health and Care Excellence. (2015). Menopause. Acc January 2017. 
  20. Australasian Menopause Society. (2014). Bioidentical hormones ofr menopausal symtoms. Accessed January 2017.
  21. Files, J., Ko, M. & Pruthi, S. (2011). Bioidentical hormone therapy. Mayo Clinic Proceedings.  86(7): 673-680.
  22. Guardard, A., et al. (2016). Bioidentical hormones for women with vasomotor symptoms. Cochrane Database of Systematic Reviews. Accessed January 2017.

Make a new account to start learning online.

Create account

Search the list of articles.

Find articles

Learn about the site and how it can help you.

Take the tour
View current newsletter

You are not yet subscribed to the newsletter.